Prot# 205.452: A randomised, active-controlled, double-blind, double-dummy, parallel group design, multi-center trial to compare the efficacy and safety of 2.5 µg and 5 µg Tiotropium Inhalation Solution delivered by the Respimat® Inhaler with Tiotropium i

Project: Research project

Project Details

StatusFinished
Effective start/end date9/23/109/23/13

Funding

  • Boehringer Ingelheim Pharmaceuticals, Inc. (205.452)